Novanta Inc. Tangible Equity Units closed at $60.49 on Sep 28, down 0.75%, 14.4% below its highest close since Nov 12. Volume of 102.4K shares was 2.46× its 20-day average (well above normal).
Split-adjusted performance: -1.9% over one month, +16.8% over six months.
In the quarter ended Jul 3, 2026, revenue was $265.81M, with a net margin of 4.7%.
Short interest was 52.1K shares at the Sep 15 settlement (15.6 days to cover).
No reported quarters with price history yet.
Percentile among 32 companies (100 = best)
Industry medians: 6-month return −27.2%, revenue growth +3.0%, net margin −41.0%, P/E 18.5×.
No recent articles focused on Novanta Inc. Tangible Equity Units. 1 articles mention it in passing.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
